Synopsys (SNPS) Stock Climbed, What Is Behind The Fresh Attention?
Why recent governance changes and investor moves matter for Synopsys stock
Synopsys (SNPS) is back in focus after an institutional investor trimmed its position, citing slower than expected growth alongside a premium valuation. At the same time, investors are assessing governance continuity as General Counsel Janet Lee prepares to step down.
See our latest analysis for Synopsys.
Over the past year, Synopsys has seen its share price drift lower despite strong interest in AI infrastructure, with a 1-year total shareholder return that declined 31.79% and a 90-day share price return that fell 16.11%. This comes even as the company continues to feature at sector events such as the OCP APAC Summit and Future of Memory and Storage conferences and progresses with leadership changes around the General Counsel role.
If Synopsys’s recent pullback has you rethinking where AI opportunities might sit, this could be a useful moment to scan a wider field of 55 AI infrastructure stocks
After a 1 year total return that declined 31.79%, along with a P/E that still screens as high and a DCF that points to a discount, is most of Synopsys’s upside already behind the stock or still in front of you?
Most Popular Synopsys Narrative: 25% Undervalued
With Synopsys last closing at $421.50 against a narrative fair value of about $559.58, the current price sits well below what this widely followed view considers reasonable, and the gap rests heavily on how investors see earnings power and cash generation compounding over time.
The acquisition and integration of Ansys positions Synopsys as the global leader in engineering solutions from silicon to systems, dramatically expanding its addressable market into sectors like automotive, industrial, and aerospace. This should drive long-term top-line growth as more sophisticated and complex products (especially AI-powered and smart devices) require robust simulation, analysis, and EDA tools.
Want to see what underpins that higher fair value for Synopsys? The story leans heavily on faster earnings growth, richer margins, and a premium future profit multiple.
Result: Fair Value of $559.58 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Synopsys still faces real pressure if export limits on China persist or if Ansys integration and headcount cuts negatively affect growth and margins.
Find out about the key risks to this Synopsys narrative.
Another view on Synopsys valuation
The first narrative suggests Synopsys is undervalued against a fair value of about $559.58. A different lens is the P/E ratio. At 104.4x, Synopsys trades at roughly 3x the peer average of 34.1x and about double the fair ratio of 51.3x, which points to meaningful valuation risk if expectations slip.
For a fuller sense of what this rich earnings multiple might imply for future returns and downside risk, take a closer look at the See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
If the mix of optimism and concern around Synopsys feels finely balanced, now is a good time to review the data and form your own view. To see both sides in one place, check out the 3 key rewards and 2 important warning signs
Looking for more investment ideas beyond Synopsys?
Before you move on, you may want to line up fresh ideas. Skipping a quick screen now could mean missing the next stock that fits your plan.
- Target resilient compounding potential by focusing on companies with strong finances and low risk scores through the 83 resilient stocks with low risk scores.
- Hunt for quality at a sensible price by scanning companies that screen as potentially mispriced with the 50 high quality undervalued stocks.
- Spot early opportunities with solid financials by checking companies highlighted in the screener containing 18 high quality undiscovered gems.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com